Biogen (BIIB) Tops Q3 EPS by 93c; updates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Revenue Growth %: +4.3%
Financial Fact:
Income before income tax expense: 1.37B
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q3 EPS of $4.81, $0.93 better than the analyst estimate of $3.88. Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.34 billion.
GUIDANCE:
Biogen sees FY2025 EPS of $14.50-$15.00, versus the consensus of $15.76.
Increased expected full year 2025 total revenue to be approximately flat to increasing 1%, at constant currency, versus full year 2024, up from approximately flat previously
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Oceaneering (OII) Misses Q3 EPS by 9c
- FS Bancorp (FSBW) Misses Q3 EPS by 48c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
